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Background: Given that patients provide the majority of their own diabetes care, patient self-management training
has increasingly become recognized as an important strategy with which to improve quality of care. However,
participation in self management programs is low. In addition, the efficacy of current behavioural interventions
wanes over time, reducing the impact of self-management interventions on patient health. Web-based
interventions have the potential to bridge the gaps in diabetes care and self-management.
Methods: Our objective is to improve self-efficacy, quality of life, self-care, blood pressure, cholesterol and glycemic
control and promote exercise in people with type 2 diabetes through the rigorous development and use of a
web-based patient self-management intervention. This study consists of five phases: (1) intervention development;
(2) feasibility testing; (3) usability testing; (4) intervention refinement; and (5) intervention evaluation using mixed
methods. We will employ evidence-based strategies and tools, using a theoretical framework of self-efficacy, then
elicit user feedback through focus groups and individual user testing sessions. Using iterative redesign the
intervention will be refined. Once finalized, the impact of the website on patient self-efficacy, quality of life, self-
care, HbA1c, LDL-cholesterol, blood pressure and weight will be assessed through a non-randomized observational
cohort study using repeated measures modeling and individual interviews.
Discussion: Increasing use of the World Wide Web by consumers for health information and ongoing revolutions
in social media are strong indicators that users are primed to welcome a new era of technology in health care.
However, their full potential is hindered by limited knowledge regarding their effectiveness, poor usability, and high
attrition rates. Our development and research agenda aims to address these limitations by improving usability,
identifying characteristics associated with website use and attrition, and developing strategies to sustain patient use
in order to maximize clinical outcomes.
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Management of diabetes is complex, and involves con-
trolling the multiple risk factors that lead to complica-
tions. Given that patients provide the majority of their
own diabetes care [1], patient self-management training
is an important strategy with which to improve quality
of care [1]. Several systematic reviews have examined
the impact of self-management interventions on gly-
cemic control, cardiac risk factors and psychological out-
comes. These reviews have demonstrated positive effects
on knowledge [2], self-reported dietary habits [2], quality
of life [3], and glycemic control [2,4]. However, effects of
interventions on lipids, physical activity, weight, and
blood pressure were variable [2]. Characteristics of ef-
fective interventions include patient collaboration and
regular reinforcement [2].
Despite this sound rationale and evidence supporting
these interventions, participation in self management
programs is low [5]. In addition, the efficacy of behav-
ioural interventions wanes over time [6], reducing the
impact of self-management interventions on patient
health. Consumers are increasingly accessing the World
Wide Web and social media as sources of health infor-
mation [7,8]. Web-based interventions have the potential
to improve diabetes care and self-management. Two sys-
tematic reviews suggest that web-based media improve
knowledge and understanding [9,10], social support [10],
behaviour change [10] and clinical outcomes [10] for a
variety of diseases. However effective education and self-
management principles have not been systematically
incorporated into existing diabetes websites for patients
to optimize these interventions. A review of existing dia-
betes websites demonstrated that these websites were
characterized by didactic information of variable quality,
high reading levels, and a newspaper-format display,
with little interactive technology, social support or
problem-solving assistance [11,12]. A recent systematic
review of electronic diabetes-related tools found that
they had moderate but inconsistent effects on a variety
of psychological and clinical outcomes including HbA1c
and weight and a high prevalence of usability errors [13].
It also found that more interactive tools resulted in con-
tinued website use and greater clinical improvement.
Thus, we sought to improve effective self-manage-
ment, as evidenced by improved self-efficacy, quality of
life, self-care, blood pressure, cholesterol and glycemic
control and exercise promotion, in people with type 2
diabetes through the use of a web-based patient self-
management intervention that addresses the identified
limitations of existing web-based interventions. Specific-
ally, we sought to ensure inclusion of evidence-based
content in a usable format, with incorporation of inter-
activity, social support and problem-solving assistance,
patient collaboration and regular reinforcement.Methods
Intervention development requires careful planning and
the use of theory-based strategies to increase the prob-
ability of effectiveness, programme adoption and imple-
mentation [14]. Graham et al’s Knowledge to Action
framework [15] was chosen for evaluating this know-
ledge translation activity (Table 1) because it is context-
focused, enables knowledge-producer and knowledge-
user collaboration, and emphasizes sustainability. The
Knowledge to Action framework incorporates the need
to adapt the knowledge to fit with the local context,
which is particularly important for this activity: this pro-
ject is occurring in the context of the provincial govern-
ment’s 5-year diabetes initiative, which includes a web-
based dissemination strategy. Secondly, this framework
is particularly useful for emphasizing the collaboration
between knowledge producers and knowledge users
throughout the process and for facilitating the use of re-
search knowledge by several stakeholders, such as prac-
titioners, policymakers, patients and the public. By
involving stakeholders in the choice of question and
interventions, the external validity of the research is
strengthened. Finally, it addresses the need to sustain
knowledge use by anticipating changes and adapting ac-
cordingly. As described above, sustainable knowledge
use is essential given the chronic nature of diabetes. In
this paper, we describe our innovative systematic ap-
proach to intervention development and evaluation.Study overview
This study consists of five phases: (1) intervention devel-
opment; (2) feasibility testing; (3) usability testing; (4)
intervention refinement; and (5) intervention evaluation
using mixed methods (repeated measure modeling, indi-
vidual interviews).Phase 1: Intervention development
Our objective was to create an evidence-based, theory-
driven self-contained website. Based on our systematic
review of electronic tools on topics relevant to diabetes
[13], we selected tools that were known to be effective,
relevant and usable. For example, we included multi-
media diabetes education modules targeting individuals
with low literacy that were demonstrated to be effective
in lowering A1c [16] and that were easy to use [13]. In
addition, we incorporated behavioral intervention strat-
egies that were found to be effective in a systematic re-
view of internet-based interventions, including stress
management and communication tools [17]. For ex-
ample, we included text- and graphic-based material on
coping with diabetes, an online forum to communicate
with peers, as well as tips and website-generated reports
to facilitate communication with health care providers.
Table 1 Knowledge-to-Action framework
Knowledge to Action framework
[15]
Study phase
Identify problem. Identify, review,
select knowledge
Patient self-management training has increasingly become recognized as an important strategy with which to
narrow the care gap. Several systematic reviews have examined the impact of diverse self-management
interventions and have demonstrated positive effects on knowledge self-reported dietary habits [6], quality of
life [3] and glycemic control [4,6]. Despite the strength of this evidence base, participation in these programs
is low. Given the growing prevalence of diabetes worldwide as well as the strong evidence base upon which
available guidelines were developed, effectively bridging the knowledge to practice gap in this area has the
potential to significantly improve health care outcomes and thus health care delivery and system
sustainability.
Adapt knowledge to local context In July 2008 the Ontario MOHLTC launched the Ontario Diabetes Strategy, to improve prevention and care for
Ontarians with chronic diseases, starting with diabetes, through a mix of prevention, access to technology,
personal planning and access to specialized resources and health professionals. All Ontarians with diabetes
and their health care providers will be supported through a series of inter-related initiatives. As part of this
larger initiative, there is an implementation plan for patient self-management tools, as well as a plan for
measuring and reporting on improvements in clinical care and outcomes on a web-based patient portal.
Assess barriers to knowledge use Barriers to knowledge use can occur at several levels, including the health care system, the health care team
and organization, the health care profession, the patient and, finally, the guidelines or their education delivery
system. Brown described a similar framework, and categorized barriers to diabetes care on three levels:
organization, provider, and patient. Barriers at the patient level include acceptance of the diagnosis,
education, self-motivation and adaptation to daily living. Poor adherence to guidelines may be a result of
patient preferences, expectations or knowledge. Our initiative will focus on barriers at the patient level.
Select, tailor, implement
interventions
(a) Selecting the intervention (Phase 1)Web-based interventions have the potential to bridge the gaps in
diabetes care and self-management. Two systematic reviews suggest that web-based media improve
knowledge or understanding [9,10], social support [10], behaviour change [10] and clinical outcomes [10] in a
variety of disease states. (b) Tailoring the intervention. The intervention will be refined following feasibility
(Phase 2) and usability testing (Phase 3) with patients with diabetes. (c) Implementing the intervention. The
refined self-management tool (Phase 4) will be implemented in a pilot study (Phase 5).
Monitor knowledge use A mixed method study, as described in the main text, will be conducted, consisting of an interrupted time
series and individual interviews (Phase 5).
Evaluate outcomes
Sustain knowledge use Barriers to sustained knowledge use will be addressed in the planning phase of tool development,
implementation and dissemination, and further explored upon completion of the pilot study with qualitative
methodology (Phase 5).
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framework of self-efficacy, a theory that has not only
been validated in predicting and promoting patient be-
havior change but has also been demonstrated to im-
prove clinical outcomes [18-25]. For example, diabetes
self-management education programs incorporating self-
efficacy have been shown in randomized controlled trials
to improve knowledge [25], health behaviour [24,25],
self-efficacy [23-25], HbA1c [23-25], and weight [25] and
microvascular complications [24]. Briefly, self-efficacy
refers to “beliefs in one’s capabilities to organize and
execute the courses of action required to produce given
attainments” [26]. It arises from one’s successes or fail-
ures during previous performances, observations of
others’ experiences, verbal persuasion and physiological
and affective states, and is mediated by cognitive, motiv-
ational, affective and selective processes. We used these
sources and mediators of self-efficacy in formatting our
site and selecting tools. For example, we incorporated
feedback, goal-setting, peer story-telling, and monitoring
tools into the website by including computer-generated
responses to user entries, a goal-setting application, vid-
eos of peer testimonials, trackers for blood glucose,blood pressure, weight and physical activity and a diary)
(Figure 1).
We also drew from the literature insights regarding
patient health information seeking behavior to promote
optimal use of the website [27]. Developed through
qualitative focus group methodology, the approach of
Longo et al. acknowledges the role of passive receipt and
active retrieval of information, as well as the role of rela-
tionships with other individuals and health care provi-
ders in helping to process and interpret information. We
used this model of health information seeking behavior
to inform the development of interfaces that would en-
able a flexible approach to information seeking. To this
end, we will automate email briefs of selected content,
optimize search algorithms to enable self-directed re-
trieval, create an online forum to permit sharing of
experiences, and develop tools (e.g. blood pressure track-
ers) and content (e.g. “How to prepare for your appoint-
ment with your physician”) to facilitate communication
with health care providers (Figure 1).
We chose to create a self-contained website that did
not require regular one-on-one input by a health care
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Figure 1 Evidence and theory-based framework for intervention development. Schematic depicting theoretical underpinnings (health
information model, self-efficacy) and evidence base (systematic reviews of electronic tools, behavior change websites) contributing to website
features.
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We will employ focus group methodology to assess ac-
ceptability, usability, sustainability, strengths and weak-
nesses of this intervention. The website will be presented
to participants who will be asked to work through the web
based tools to complete a task that simulates real clinical
use. The task invites participants to use the website to de-
termine their personal risk of heart disease and specific
strategies to reduce this risk, including the role of blood
pressure in vascular risk and methods to reduce their
blood pressure.
Participants
A purposive sampling strategy will be used to generate a
heterogeneous group that captures the perspectives of pa-
tient participants with varied experiences. Participants
(age greater than 25 years) with varied socio-demographic
profiles (e.g. gender, age, use of insulin, ethnicity, educa-
tional attainment, annual income) and technological profi-
ciency will be recruited from diabetes care centers at two
academic health science centers in Toronto, Canada, and
will complete a baseline questionnaire of user demograph-
ics. A sample size of 3 focus groups is estimated to achieve
saturation of themes and to generate sufficient feedback
to refine the tool; while sample size of 5–8 people isgenerally required for a homogeneous group, we wanted
to sample a heterogeneous group as outlined above [28].Outcomes
We will probe about intervention content, such as web-
site title, general website organization, website searching
tools, format of interactive and didactic tools, and con-
tent that they would find valuable. We are also inter-
ested in intervention processes, such as barriers and
facilitators to the adoption of the specific tools and of
the website generally, factors affecting continued use,
reasons to visit the site repeatedly, the role of social net-
working, and comfort with entering personal informa-
tion online. We want to determine features of the
components that are perceived by participants to be
valuable, and those which are in need of further
development.Data collection
Focus group sessions will employ semi-structured inter-
view guides developed by team members with know-
ledge translation and qualitative research expertise [29].
Face and content validity of this guide will be assessed
with team members and refined as needed. All focus
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field notes kept.
Data analysis
Audiotapes will be transcribed verbatim [30]. In keeping
with qualitative methodology, data analysis will occur in
conjunction with data collection [31]. Transcripts will be
coded for emergent categories and themes using con-
stant comparison [31]. All transcripts will be coded and
reviewed independently by three team members with ex-
pertise in qualitative research methods; consensus on
coding will be reached through comparison, discussion,
and agreement among these three reviewers. Further,
memos kept by the qualitative team members will be
used to help monitor the emergent analytic framework
and regular meetings will enable continued dialogue and
discussion within the project [32]. NVivo software (ver-
sion 9) will be used to assist data management and
monitor the emerging analysis.
Phase 3: Usability testing
We will conduct usability testing sessions using cogni-
tive task analysis [33], whereby users are individually
asked to “think aloud” as they perform specific tasks
representing scenarios designed to cover the major func-
tionalities of the web-based intervention in a one-hour
session. We plan to do additional cycles of usability test-
ing after intervention refinement in an iterative process
of evaluation and redesign.
Participants
A consecutive sample of ten participants with type 2 dia-
betes aged greater than 25 years will be recruited from
diabetes care centers at two academic health science
centers in Toronto, Canada. The sample size should be
sufficient, as research has shown that up to 80% of us-
ability issues can be identified with 5 to 8 participants
[33].
Outcomes
Data regarding paths users take to accomplish tasks,
errors made, when and where they encountered confu-
sion or frustration, time spent, and degree of satisfaction
will be generated.
Data collection
A consultant with expertise in health informatics and
human factors engineering will conduct each session,
and further prompt users with a structured interview
guide on usability. All usability testing sessions will be
video and audio-taped. In addition, field notes will be
kept of all sessions as a further source of data for ana-
lysis. Video tapes of the computer screen will be used to
capture user actions in response to prompted tasks.Data analysis
Audio tapes will be transcribed verbatim. Transcripts
will be coded for emergent categories and themes using
constant comparison [31]. Transcripts will be coded and
reviewed independently by three team members with ex-
pertise in qualitative research methods, and consensus
on the coding framework will be reached [34,35]. NVivo
software (version 9) will be used to assist with data man-
agement and retrieval for analysis. Video tapes will be
used in conjunction with audio tapes to identify the area
of the website in discussion and user actions recorded.
Phase 4: Intervention refinement
Based on data from the feasibility testing, refinements
will be made to the website via ongoing discussion with
the research and development team. Similarly, following
usability testing, further refinements will be made to the
website in an iterative process of testing and redesign.
We anticipate that refinement will occur over a one-
month period.
Phase 5: Intervention evaluation
We hypothesize that a web-based patient self-management
intervention, developed and revised based on our usability
and feasibility testing, will result in improvements in self-
care score, self-efficacy score, health care user satisfaction
score and quality of life score in patients with type 2 dia-
betes with access to the internet.
Observational cohort study
Participants
A consecutive sample of individuals aged> 25 years with
hemoglobin A1c (HbA1c) > 7.0%, systolic blood pressure
(sBP) > 130 mmHg, low-density-lipoprotein cholesterol
(LDL-C)>2.0 mmol/L or a body mass index (BMI) > 25 kg/
m2 will be recruited from 2 family practice units and 2
endocrinology clinics at 2 urban academic health science
centers in Toronto. Those with active heart disease (defined
as Canadian Cardiovascular Society class 3 to 4 angina),
who were non-English-speaking, who were not available for
follow-up, or who had no regular access to the telephone
or internet will be excluded. Age, gender, ethnicity, educa-
tion, employment, duration of diabetes, complications,
smoking status, anti-hyperglycemic, antihypertensive, and
lipid-lowering agents, HbA1c, sBP, LDL-C, weight, current
use and comfort with computer and internet, self-care
score, self-efficacy score, health care user satisfaction score
and quality of life score will be obtained at baseline.
Outcomes
Primary outcome
The primary outcome, self efficacy, will be assessed with
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which has moderate to high reliability (Cronbach’s
alpha = 0.51 to 0.86) [36,37] (Table 2).Secondary outcomes
Secondary outcomes include self care and quality of life,
which will be assessed through well-validated scales,
described below and in Table 2.
Self-care behavior will be assessed with the Summary
of Diabetes Self-Care Activities Measure – Revised. Reli-
ability and validity for this instrument have been
reported to be fair, with a test-retest correlation of 0.40
and internal consistency of 0.47 [38,39].
Diabetes-specific quality of life will be assessed with
the Diabetes Distress Scale which has been found to
have high internal reliability with a Cronbach’s alpha of
0.93, good convergent validity with the Center for Epi-
demiological Studies Depression Scale (CESD) (r = 0.56)
and self-care behaviors including lower adherence to eat-
ing recommendations (r = 0.30, p < 0.001) and lower
levels of physical activity (r = 0.13, p < 0.01) [40]. In
addition, diabetes distress has been demonstrated to be
associated with HbA1c (r = 0.17-0.31, P= .00-.001), diet
(r =−0.38, P= .00), physical activity (r =−0.13, P= .01)
and medication adherence (r =−0.16, P= .00) [41,42].
These patient-based outcomes were selected because
they are direct and relevant measures of knowledge use
by patients. Diabetes self-care is a direct measure of
knowledge use, and self-efficacy was chosen in order toTable 2 Description of primary outcome scales
Outcome Scale
Self-efficacy Modified Grossman Self-efficacy
for Diabetes Scale [36,37]
The scale contains 25 ite
regimen. Subjects are ask
was stated. The response
do what was stated in ea
perform the designated




Summary of Diabetes Self-Care
Activities Measure – Revised
[38,39]
Items selected from this
7 days) of engaging in d
out carbohydrates evenly
testing, foot care, and m
participants are asked to
7 days. . .” Responses, wh
number of days indicate
been found to be adequ
Diabetes-specific
quality of life
Diabetes Distress Scale [40] The DDS is a 17 item ins
living with diabetes. Resp
6 = “serious problem”. Sco
diabetes-related quality o
The DDS has been found
convergent validity with
and self-care behaviours
p < 0.001) and lower leve
has been demonstrated
P = .00), physical activitybetter understand the mediating variables of knowledge
use. Quality of life was chosen as a more holistic and
patient-centered measure of impact of knowledge use.
HbA1c, systolic and diastolic blood pressure, LDL-C
and weight to be collected every 3 months; these out-
comes were chosen to help inform sample size calcula-
tions of future prospective trials.Data collection
Data on outcomes will be collected by patient-completed
questionnaires; patients will be compensated with a small
honorarium for each questionnaire. For the pre-
implementation phase, aggregates of patient data will be
obtained every three weeks for nine months, resulting in
12 data points. The intervention will then be implemen-
ted. For the post-implementation phase, aggregates of pa-
tient data will be obtained every three weeks for nine
months following the intervention, resulting in another 12
data points. HbA1c and LDL-C will be collected from the
hospital medical records. Systolic and diastolic blood pres-
sure will be collected by the research coordinator with an
Omron Blood Pressure Model (Model no. HEM-907XL)
and recorded as the average of 3 readings. Weight will be
collected by the research coordinator with a Seca digital
scale (Model 707). Web server log analysis will be done to
assess frequency and duration of the specific components
of the intervention; metrics selected are described in Ap-
pendix C. All participants will be asked at the end of the
study to disclose whether other web-based interventionsDescription
ms that measure the intensity of self-efficacy for activities of the diabetes
ed to describe how much they believe they could or could not do what
s on this 6-point scale range from “very sure I can’t” to “very sure I can”
ch item. Higher scores indicate greater confidence in one’s ability to
treatment activities. The following statements are examples of the self-
eals and snacks at home” and “Keep track of blood sugar levels”. The
le has a moderate to high reliability (Cronbach’s alpha = 0.51 to 0.86).
self-report instrument assess participants’ frequency (over the past
iabetes self-care behaviors, including following a healthy diet, spacing
across the day, physical activity, self-monitoring of blood glucose
edication and/or insulin taking. For each diabetes self-care behavior,
respond using the following prompt: “On how many of the last
ich are based on a 7-day week, range from 0 days to 7 days. Greater
d better self-management. Reliability and validity for this instrument have
ate, with a test-retest correlation of 0.40 and internal consistency of 0.47.
trument that assesses emotional distress and functioning specific to
onses are scored on a 6-point Likert-type scale from 1= “no problem” to
res can range from 17–102 with higher scores indicating poorer
f life and lower scores indicating better diabetes-related quality of life.
to have high internal reliability with a Cronbach’s alpha of 0.93, good
the Center for Epidemiological Studies Depression Scale (CESD) (r = 0.56)
including lower adherence to eating recommendations (r = 0.30,
ls of physical activity (r = 0.13, p < 0.01) [40]. In addition, diabetes distress
to be associated with HbA1c (r = 0.17-0.31, P = .00-.001), diet (r =−0.38,
(r =−0.13, P = .01) and medication adherence (r =−0.16, P = .00) [41,42].
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image-based didactic materials, interactive technology or
behavioral strategies.
Sample size calculation
Using a range of correlations from 0.2-0.8, a 0.05 signifi-
cance level, and a power of 80%, a sample of at most 52
subjects is required to detect a change of 0.5 units in
self-efficacy score before the intervention as compared
to after. A formula for paired mean comparisons was
used [43] and the longitudinal nature of the study will
only increase the power [44]. The sample size was fur-
ther adjusted to account for a 40% expected dropout
rate (attrition).
Data analysis
Descriptive analysis will examine the distribution of each
variable of interest and determine which variables are suit-
able as covariates for modeling. In addition, exploratory
and graphical measures will be used for each of the pri-
mary and secondary outcomes to determine the distribu-
tion of the outcome of interest to enable a suitable
statistical model to be constructed. Should the distribution
of the outcome not be ideal, a suitable transformation will
be used to enable proper statistical modeling [45,46]. The
primary analysis, assessing the effect of the intervention
on self-efficacy, will be examined using a linear mixed
model to account for inherent correlation of the repeated
measures within each individual [47]. The model will
examine the effect of intervention on the outcome, self-ef-
ficacy, while adjusting for the following variables: age, eth-
nicity, education level, employment status, income (above
or below $30 000) and health literacy. Should the data
support it the model will also include interactions of these
variables with the intervention to determine whether the
impact of the intervention on self-efficacy varies for differ-
ent levels of the variables. Time will also be included in
the model to adjust for any trends over time. Model diag-
nostics will be performed using residual analysis.
Similar modeling will be used for the other outcomes
of self-care and quality of life as well as A1C, systolic BP,
diastolic BP, LDL and weight. For secondary outcomes,
due to the data being collected less frequently, fewer
variables will be included in the model. Each model in
the secondary analysis will examine the effect of the
intervention while adjusting for self-efficacy, income and
ethnicity. In addition to these covariates, the outcomes
systolic BP, diastolic BP and LDL will also include age as
a covariate while the analysis examining weight as the
dependent variable will also include insulin use as a cov-
ariate. Should the data support it these variables will also
be examined as interaction terms with the intervention.
This analysis approach will allow us to examine the ef-
fect of the intervention on each of the primary andsecondary outcomes while adjusting for other important
variables and accounting for the correlation that arises
in repeated measures data.
Other variables of interest such as website usage statis-
tics, website user satisfaction and subscales of self-effi-
cacy, self-care and quality of life will be examined using
descriptive and graphical analysis.
In-depth interviews
Following completion of the repeated measures study,
in-depth focused, individual interviews will be used to
assess acceptability, usability, strengths and weaknesses
of the intervention, facilitators and barriers to its use,
user satisfaction, and sustainability of use.
Participants
A purposive sample of participants (based on gender,
age, ethnicity, duration of diabetes, educational attain-
ment, annual income, pre-intervention experience with
website use) from the repeated measures study will be
recruited by the study coordinator. A sample size of 25
participants is likely to be necessary to achieve theoret-
ical saturation.
Outcomes
The perceived impact of each web tool on participants’
knowledge of diabetes self-management, perceptions
regarding their experiences of diabetes and how it
impacts their lives, stage of behavior change, perceived
self-efficacy and self-management will be assessed,
prompted by open-ended questions from the inter-
viewer. Participants’ perspectives regarding barriers and
facilitators to the adoption and sustained use of a web-
based intervention, types of information included and
formats used (and preferred) will be discussed. Accounts
of their use of other health information resources, their
interaction with the healthcare system, and their percep-
tions of online privacy and sharing will also be explored.
Data collection and analysis
All interviews will be audio tapes and transcribed verba-
tim [30]. Transcripts will be coded for emergent categories
and themes using constant comparison [31]. Transcripts
will be coded and reviewed independently by three team
members with expertise in qualitative research methods.
A coding framework will be developed based on the emer-
ging analysis, and then tested and refined with subsequent
interviews in an iterative process. The coding framework
will be based on consensus amongst the analysts [34,35].
NVivo software (version 9) will be used to assist with data
management and retrieval for analysis. In addition, the
qualitative data will be compared with the quantitative
data in order to triangulate and interpret both datasets in
the context of the whole study [48].
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While the first two phases of this study will shed light
on information needs of patients with type 2 diabetes,
our subsequent phases will assess the impact of this
systematically developed intervention. Specifically, the
repeated measures design will determine the impact of
web-based self-management programs on important
psychological and clinical outcomes. We will also iden-
tify factors (both of participants and of the website) that
correlate with website use and effectiveness in order to
guide future intervention development and research.
Strengths and limitations
Strengths of our approach include our rigorous theory-
driven and evidence-based approach to intervention de-
velopment, our systematic refinement of the interven-
tion based on feasibility and usability data, our use of
mixed methods for evaluation, and our selection of us-
ability assessment techniques. The importance of theory
was highlighted in a recent systematic review which
found that effectiveness of internet-based interventions
is associated with more extensive use of theory [17].
Similarly, evidence-based content should form the foun-
dation of an educational website, yet pre-existing dia-
betes websites have wide variations in the quality of
evidence leveraged [11]. Finally, stakeholder input and
usability testing are key to intervention implementation
and sustainability [49] but are frequently neglected, with
up to 60% of diabetes-related websites having at least
three usability errors [13]. These elements of design –
theory, evidence, stakeholder input, and usability testing
- are fundamental to intervention effectiveness and
should represent the gold standard for intervention de-
velopment [13].
Within the qualitative evaluation, we will use trained
moderators who are not otherwise invested in the project,
collect background information regarding participants to
ensure that there is diverse representation, and use a
sound methodology for coding and interpreting the data
into relevant themes, including independent coding by
two individuals and interpretation by three individuals to
ensure data trustworthiness [50]. In addition, triangulation
of the qualitative findings with the quantitative results will
promote methodological rigor [48]. One limitation of our
usability testing approach is that this technique may miss
consistency problems (for example, conventions, such as
an arrow indicating “next”, not being used consistentlythroughout the website). However, we will address this
issue by ensuring that our sessions are moderated and
analyzed by a usability expert.
Potential limitations of our evaluation study include the
consistency with which participants will respond at each
time point, generalizability, as well as maturation and his-
tory threats to internal validity. Response rate will be max-
imized with the use of reminder emails and honoraria. We
will maximize generalizability by recruiting broadly across
all socio-demographic strata and by collecting data to
allow us to characterize our study populations. We will ac-
count for maturation threats by assessing for interaction
with time, and we will assess for history threats by record-
ing secular events that could impact on our outcomes
prospectively throughout the study period and by asking
our participants on their exit questionnaires.
Conclusions
Web-based interventions to improve self-management
of diabetes show great promise because they target pa-
tient behaviors directly, can be easily scaled up given the
fixed cost of website development and are inexpensive
to maintain. This study builds on previous work using
the most rigorous approach to intervention develop-
ment, including usability testing, qualitative studies of
acceptability, iterative refinement, and measures the im-
pact on self-efficacy, quality of life and risk factor con-
trol using a repeated measures design. Our intervention
is based robustly on a theoretical foundation of self-effi-
cacy, which has been demonstrated to predict and pro-
mote behavior change and improve health outcomes in
chronic diseases such as diabetes mellitus. In addition,
use of behavior change theory itself in intervention de-
velopment is associated with greater intervention effect-
iveness. This, in combination with evidence-based
content and strategies, stakeholder input and usability
testing, should result in an optimally engineered website
designed to improve psychological and clinical outcomes
and complement health care delivery. Increasing use of
the World Wide Web by consumers for health informa-
tion and ongoing revolutions in social media are strong
indicators that consumers are primed to welcome a new
era of technology in health care. However, their full po-
tential is hindered by limited knowledge regarding their
effectiveness, high prevalence of usability errors, and
high attrition rates. Our development and research
agenda aims to address these limitations by assessing ef-
fectiveness, addressing usability errors, identifying char-
acteristics associated with website use and attrition, and
developing strategies to reduce website attrition in order
to maximize clinical outcomes.
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